# Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography

> **NCT06164392** · PHASE4 · WITHDRAWN · sponsor: **Northwestern University**

## Conditions studied

- Neuroma
- Neuroma Amputation
- Neuroma of Upper Limb
- Neuroma of Lower Limb

## Interventions

- **DRUG:** Indocyanine green

## Key facts

- **NCT ID:** NCT06164392
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-12-28
- **Primary completion:** 2024-12-28
- **Final completion:** 2024-12-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The attendings who were to participate did not want to alter their standard neuroma treatment of neurotomy and TMR, as opposed to dissecting the end of all neuromas before neurotomy. No patients were enrolled in the study.
- **Last updated:** 2025-01-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06164392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06164392, "Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06164392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*